DRI Healthcare Trust Reports Second Quarter 2023 Results
– Continued strong portfolio performance with 16% royalty income growth over prior year period – – Deployment of US$284 million since April 1 showcases Trust’s ability to execute – – Capital inflows of US$339 million from royalty sale, debt repayment and follow-on equity offering combined with attractive credit facilities provide significant cash for deployment – […]
DRI Healthcare Trust Announces Acquisition of a Second Royalty Interest in the Worldwide Sales of ORSERDU® (elacestrant) and Updates Long-Term Guidance
– Proceeds from follow-on offering quickly redeployed into value accretive transaction – – DRI Healthcare’s third significant royalty acquisition within six weeks – – Now expecting mid-teens total income CAGR through 2025 and low single digit total income CAGR through 2030, excluding any new transactions – TORONTO, Aug. 14, 2023 /CNW/ – DRI Healthcare Trust […]
DRI Healthcare Trust Announces Participation in Upcoming Investor Conferences
TORONTO, July 25, 2023 /CNW/ – DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI” or “the Trust”) today announced that the Trust intends to participate in the following investor conferences in 2023: Canaccord Genuity Annual Growth Conference Date: August 9, 2023 Presentation time: 9:30 am ET City: Boston, Massachusetts Event URL: https://www.canaccordgenuity.com/capital-markets/about-us/events/43rd-annual-growth-conference/ CIBC 22nd Annual […]
DRI Healthcare Trust to Host Second Quarter Earnings Call and Webcast on August 15, 2023
TORONTO, July 25, 2023 /CNW/ – DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI” or “the Trust”) announced today it will hold a conference call to discuss its second quarter 2023 financial results on Tuesday, August 15, 2023, at 8:00 a.m. ET. The Trust will report its financial results on Monday, August 14, 2023, after market […]
DRI Healthcare Trust Completes C$98 Million Bought Deal Public Offering of Units
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, July 19, 2023 /CNW/ – DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (the “Trust”), a global leader in providing financing to advance innovation in the life sciences industry, announced today that it has completed its previously announced bought deal public offering of […]
DRI Healthcare Trust Announces C$85 Million Bought Deal Public Offering of Units
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, July 12, 2023 (GLOBE NEWSWIRE) — DRI Healthcare Trust (TSX: DHT.UN/DHT.U) (the “Trust”), a global leader in providing financing to advance innovation in the life sciences industry, announced today that it has entered into an agreement with a syndicate of underwriters […]
DRI Healthcare Trust Announces Acquisition of an Additional Royalty Interest in the Worldwide Sales of VONJO® (pacritinib)
– Uncapped deal structure complements current VONJO royalty entitlement – – Now projecting Total Income CAGR at high end of our 7-9% guidance through 2025 and flat to slightly growing Total Income until 2030 – – The transaction extends DRI’s overall portfolio duration to over 10 years – TORONTO, July 7, 2023 /CNW/ – DRI […]
DRI Healthcare Trust Announces Acquisition of a Royalty Interest in the Worldwide Net Sales of Orserdu™ (elacestrant) and Reiterates Long-Term Cash Receipts Outlook
– Patent-protected exclusivity and uncapped deal structure offers attractive return profile – – Acquisition generates substantial near-term cash flows and long-term portfolio growth – – DRI Healthcare expects flat to slightly growing cash receipts through 2030 – TORONTO, June 30, 2023 /CNW/ – DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (the “Trust”), a global leader in providing […]
DRI Healthcare Trust Announces US$54.8 Million Debt Repayment from CTI BioPharma Corp.
– Provides additional deployment capacity in pursuing attractive deals in high-quality pipeline – TORONTO, June 26, 2023 /CNW/ – DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (the "Trust"), a global leader in providing royalty financing to accelerate therapeutic innovation in the life sciences industry, announces that CTI BioPharma Corp. ("CTI") has prepaid all amounts outstanding […]
DRI Healthcare Trust Announces Voting Results of AGM
TORONTO, May 12, 2023 /CNW/ – DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) ("DRI" or "the Trust") is pleased to announce results of voting at its annual general meeting ("AGM") of unitholders held on May 12, 2023. All of the nominees for election as trustees of the Trust referred to in its management information circular dated March 29, […]